BANK BRADESCO current report, Q3 FY2026

Business context and reporting period

Banco Bradesco S.A. filed this Form 6-K for September 2026. The September 30, 2026 announcement concerns the auction of shares left unsubscribed in the company’s capital increase through the subscription of new shares; it does not report quarterly financial results.

Capital increase and auction details

  • After the subscription-rights period and related payments ended, 1,505,454 common-share subscription receipts and 14,553,057 preferred-share subscription receipts remained unsubscribed.
  • The receipts represent 2.65% of the total shares issued in the capital increase: 0.50% of total common shares and 4.82% of total preferred shares, as stated in the filing.
  • The receipts were scheduled for auction on B3 on October 2, 2026, at 10:30 a.m. Minimum prices were R$15.43 per common-share receipt and R$17.64 per preferred-share receipt. Ágora Corretora de Títulos e Valores Mobiliários S.A. is identified as intermediary.
  • Investors may participate through brokerage firms authorized to operate on B3, subject to the auction notice and procedures.

Material changes and financial metrics

The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics. It reports the remaining unsubscribed shares and the planned auction; comparable-period financial data are not provided.

Outlook, conditions, and risks

The subscription receipts are to convert into the corresponding shares following approval of the capital increase by the Central Bank of Brazil (BACEN). Once BACEN approval is obtained, the issued shares will be entitled to full dividends, interest on shareholders’ equity, and other distributions declared by the company. The filing does not state when approval will be granted.

Bradesco says it will provide updates on the capital increase, including BACEN approval. Its forward-looking-statement notice cautions that expectations are subject to economic, market, industry, and operating risks, and actual outcomes may differ materially.

Important facts for investors to verify

  • Whether the auction occurred as scheduled and the final quantities and prices allocated.
  • Whether BACEN approved the capital increase and when the subscription receipts were converted into shares.
  • The final share count and resulting dilution, and the timing of eligibility for any declared distributions.
  • Any subsequent company or B3 notices providing auction results or regulatory updates.